Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells

Scholarly Works

• Eldehna, W. M.; Fares, M.; Bonardi, A.; Avgenikos, M.; Baselious, F.; Schmidt, M.; Al-Warhi, T.; Abdel-Aziz, H. A.; Rennert, R.; Peat, T. S.; Supuran, C. T.; Wessjohann, L. A.; Ibrahim, H. S. 4-(Pyrazolyl)benzenesulfonamide Ureas as Carbonic Anhydrases Inhibitors and Hypoxia-Mediated Chemo-Sensitizing Agents in Colorectal Cancer Cells. Journal of medicinal chemistry 2024. doi:10.1021/acs.jmedchem.4c01894
• Llanes, D.; Rennert, R.; Jänicke, P.; Morgan, I.; Reguera, L.; Rivera, D. G.; Ricardo, M. G.; Wessjohann, L. A. Development of bombesin-tubulysin conjugates using multicomponent chemistry to functionalize both the payload and the homing peptide. Frontiers in Pharmacology 2024, 15. doi:10.3389/fphar.2024.1408091
• Ricardo, M. G.; Llanes, D.; Rennert, R.; Jänicke, P.; Rivera, D. G.; Wessjohann, L. A. Improved Access to Potent Anticancer Tubulysins and Linker-Functionalized Payloads Via an All-On-Resin Strategy. Chemistry (Weinheim an der Bergstrasse, Germany) 2024, 30, e202401943. doi:10.1002/chem.202401943
• Lam, Y. T. H.; Hoppe, J.; Dang, Q. N.; Porzel, A.; Soboleva, A.; Brandt, W.; Rennert, R.; Hussain, H.; Davari, M. D.; Wessjohann, L.; Arnold, N. Purpurascenines A-C, Azepino-Indole Alkaloids from Cortinarius purpurascens: Isolation, Biosynthesis, and Activity Studies on the 5-HT2A Receptor. Journal of natural products 2023, 86, 1373–1384. doi:10.1021/acs.jnatprod.2c00716
• Sánchez, M. L.; Rodríguez, F. D.; Coveñas, R. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies. International journal of molecular sciences 2023, 24, 9962. doi:10.3390/ijms24129962
• Xiangrong, X.; Yao, L.; Yao, A. The Recent Developments of ADCs with the Tubulysins as the Payloads. Mini reviews in medicinal chemistry 2023, 23, 1797–1805. doi:10.2174/1389557523666230220121648
• Fu, C.; Yu, L.; Miao, Y.; Liu, X.; Yu, Z.; Wei, M. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?. Acta pharmaceutica Sinica. B 2022, 13, 498–516. doi:10.1016/j.apsb.2022.07.020
• Rodríguez-Mejía, L. C.; Romero-Estudillo, I.; Rivillas-Acevedo, L. A.; French-Pacheco, L.; Silva-Martínez, G. A.; Alvarado-Caudillo, Y.; Colín-Castelán, D.; Rodríguez-Ríos, D.; Wrobel, K.; Wrobel, K.; Lund, G.; Zaina, S. The DNA Methyltransferase Inhibitor RG108 is Converted to Activator Following Conjugation with Short Peptides. International Journal of Peptide Research and Therapeutics 2022, 28. doi:10.1007/s10989-022-10390-5
• Dube, M.; Saoud, M.; Rennert, R.; Fotso, G. W.; Andrae-Marobela, K.; Imming, P.; Häberli, C.; Keiser, J.; Arnold, N. Anthelmintic Activity and Cytotoxic Effects of Compounds Isolated from the Fruits of Ozoroa insignis Del. (Anacardiaceae). Biomolecules 2021, 11, 1893. doi:10.3390/biom11121893
• Lin, S.-T.; Li, Y.-Z.; Sun, X.-Q.; Chen, Q.-Q.; Huang, S.-F.; Lin, S.; Cai, S.-Q. Update on the Role of Neuropeptide Y and Other Related Factors in Breast Cancer and Osteoporosis. Frontiers in endocrinology 2021, 12, 705499. doi:10.3389/fendo.2021.705499
• Newman, D. J. doi:10.1002/0471266949.bmc119.pub2
• Rongjun, H.; Jia, P.; John, P. M.; Fa, L. The Chemical Methods of Disulfide Bond Formation and Their Applications to Drug Conjugates. Current Organic Chemistry 2020, 23, 2802–2821. doi:10.2174/1385272823666191202111723
• Kienast, C.; Gunga, H.-C.; Steinach, M. Neuropeptide Y – Its role in human performance and extreme environments. REACH 2019, 14-15, 100032. doi:10.1016/j.reach.2019.100032

Explore citations to this article at